Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by lscfaon Nov 29, 2022 1:41pm
117 Views
Post# 35137256

RE:government financing I see GREEN

RE:government financing I see GREENThe feds just invested $27 million into E3, an pre-revenue Alberta lithium producer. VM's project  requires more effort to convince the feds to invest compared to the lithium EV battery space which is a hot topic.  


https://www.canada.ca/en/innovation-science-economic-development/news/2022/11/government-of-canada-invests-in-e3-lithium-to-advance-canadas-ev-battery-production.html




biggdogg wrote: from powerplay interview, they are applying for grants and debt from government, with carbon neutral, this is highly probable. The sellers are not too bright. With gov funding any additional funding will be easily aquired. They are marketing their brand now, it will not be too long before they have first sale. I would suspect that Alberta government is going to buy this product to suppoert a local produced contrast drug. And get their plant built to create jobs and diversify the AB economy. All looks great. Keep dumping shares, I am sure there is a small financing coming to take them over the hump, only a few will get in on this next deal. Debt financing is coming, the green component ensures this.


<< Previous
Bullboard Posts
Next >>